On the activation of soluble guanylyl cyclase by nitric oxide

被引:97
作者
Bellamy, TC
Wood, J
Garthwaite, J
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6AU, England
[2] GlaxoSmithKline Inc, Stat Sci, Harlow CM19 5AW, Essex, England
关键词
D O I
10.1073/pnas.012368499
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Soluble guanylyl cyclase (sGC) is the major cellular receptor for the intercellular messenger nitric oxide (NO) and mediates a wide range of physiological effects through elevation of intracellular cGMP levels. Critical to our understanding of how NO signals are decoded by receptive cells and translated into a useful physiological response is an appreciation of the molecular and kinetic details of the mechanism by which NO activates sGC. It is known that NO binds to a haem prosthetic group on the receptor and triggers a conformational change that increases the catalysis of cGMP synthesis by several hundred-fold. The haem is covalently attached to sGC at His-105 of the beta1 subunit, and it was thought previously that activation of sGC by NO occurs in two steps: binding of NO to the haem to form a biliganded state and then rupture of the bond to His-105 triggering an increase in catalytic activity. A recent investigation of the kinetics of sGC activation [Zhao, Y., Brandish, P. E., Ballou, D. P. & Marletta, M. A. (1999) Proc. Natl. Acad. Sci. USA, 96, 14753-14758], however, proposed an additional mechanism by which NO regulates sGC activity, namely, by influencing the rate of cleavage of the His-105 bond. The existence of a second (unidentified) NO-binding site on the enzyme was hypothesized and suggested to be fundamental to cellular NO-signal transduction. Here, we show that it is unnecessary to postulate any such additional mechanism because the results obtained are predicted by the simpler model of sGC activation with a single NO-binding event.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 28 条
  • [11] Soluble guanylate cyclase: the forgotten sibling
    Hobbs, AJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (12) : 484 - 491
  • [12] Bright and dark sides of nitric oxide in ischemic brain injury
    Iadecola, C
    [J]. TRENDS IN NEUROSCIENCES, 1997, 20 (03) : 132 - 139
  • [13] ACTIVATION OF PURIFIED SOLUBLE GUANYLATE-CYCLASE BY PROTOPORPHYRIN-IX
    IGNARRO, LJ
    WOOD, KS
    WOLIN, MS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (09): : 2870 - 2873
  • [14] Kröncke KD, 1998, CLIN EXP IMMUNOL, V113, P147
  • [15] Unprecedented proximal binding of nitric oxide to heme: implications for guanylate cyclase
    Lawson, DM
    Stevenson, CEM
    Andrew, CR
    Eady, RR
    [J]. EMBO JOURNAL, 2000, 19 (21) : 5661 - 5671
  • [16] EPR characterization of axial bond in metal center of native and cobalt-substituted guanylate cyclase
    Makino, R
    Matsuda, H
    Obayashi, E
    Shiro, Y
    Iizuka, T
    Hori, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) : 7714 - 7723
  • [17] Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: Influence of nitric oxide scavengers and calcium
    Margulis, A
    Sitaramayya, A
    [J]. BIOCHEMISTRY, 2000, 39 (05) : 1034 - 1039
  • [18] MONCADA S, 1991, PHARMACOL REV, V43, P109
  • [19] Coordination of calcium signalling by endothelial-derived nitric oxide in the intact liver
    Patel, S
    Robb-Gaspers, LD
    Stellato, KA
    Shon, M
    Thomas, AP
    [J]. NATURE CELL BIOLOGY, 1999, 1 (08) : 467 - 471
  • [20] Functional properties of a naturally occurring isoform of soluble guanylyl cyclase
    Russwurm, M
    Behrends, S
    Harteneck, C
    Koesling, D
    [J]. BIOCHEMICAL JOURNAL, 1998, 335 : 125 - 130